These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
302 related articles for article (PubMed ID: 23222498)
1. Use and spending on antineoplastic therapy for Medicare beneficiaries with cancer. Davidoff AJ; Shaffer T; Erten MZ; Shoemaker JS; Zuckerman IH; Pandya N; Stuart BC; Bryant-Comstock LG; Shenolikar R Med Care; 2013 Apr; 51(4):351-60. PubMed ID: 23222498 [TBL] [Abstract][Full Text] [Related]
2. Out-of-pocket health care expenditure burden for Medicare beneficiaries with cancer. Davidoff AJ; Erten M; Shaffer T; Shoemaker JS; Zuckerman IH; Pandya N; Tai MH; Ke X; Stuart B Cancer; 2013 Mar; 119(6):1257-65. PubMed ID: 23225522 [TBL] [Abstract][Full Text] [Related]
3. Out-of-pocket health spending by poor and near-poor elderly Medicare beneficiaries. Gross DJ; Alecxih L; Gibson MJ; Corea J; Caplan C; Brangan N Health Serv Res; 1999 Apr; 34(1 Pt 2):241-54. PubMed ID: 10199672 [TBL] [Abstract][Full Text] [Related]
4. The effect of supplemental medical and prescription drug coverage on health care spending for Medicare beneficiaries with cancer. Erten MZ; Davidoff AJ; Zuckerman IH; Shaffer T; Dougherty JS; Ke X; Stuart B Value Health; 2014; 17(1):15-21. PubMed ID: 24438713 [TBL] [Abstract][Full Text] [Related]
5. Health insurance and health at age 65: implications for medical care spending on new Medicare beneficiaries. Hadley J; Waidmann T Health Serv Res; 2006 Apr; 41(2):429-51. PubMed ID: 16584457 [TBL] [Abstract][Full Text] [Related]
6. Impact of Medicare Part D for Medicare-age adults with arthritis: prescription use, prescription expenditures, and medical spending from 2005 to 2008. Cheng LI; Rascati KL Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1423-9. PubMed ID: 22508663 [TBL] [Abstract][Full Text] [Related]
7. Analysis of Proposed Medicare Part B to Part D Shift With Associated Changes in Total Spending and Patient Cost-Sharing for Prescription Drugs. Hwang TJ; Jain N; Lauffenburger JC; Vokinger KN; Kesselheim AS JAMA Intern Med; 2019 Mar; 179(3):374-380. PubMed ID: 30640379 [TBL] [Abstract][Full Text] [Related]
8. The Effect of Medicare Part D on Prescription Drug Spending and Health Care Use: 6 Years of Follow-up, 2007-2012. Park T; Jung J J Manag Care Spec Pharm; 2017 Jan; 23(1):5-12. PubMed ID: 28025927 [TBL] [Abstract][Full Text] [Related]
9. Impact of cost sharing on prescription drugs used by Medicare beneficiaries. Goedken AM; Urmie JM; Farris KB; Doucette WR Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109 [TBL] [Abstract][Full Text] [Related]
10. Implementation of Medicare Part D and nondrug medical spending for elderly adults with limited prior drug coverage. McWilliams JM; Zaslavsky AM; Huskamp HA JAMA; 2011 Jul; 306(4):402-9. PubMed ID: 21791689 [TBL] [Abstract][Full Text] [Related]
11. Falling into the doughnut hole: drug spending among beneficiaries with end-stage renal disease under Medicare Part D plans. Patel UD; Davis MM J Am Soc Nephrol; 2006 Sep; 17(9):2546-53. PubMed ID: 16855016 [TBL] [Abstract][Full Text] [Related]
12. Medicare spending by beneficiaries with various types of supplemental insurance. Khandker RK; McCormack LA Med Care Res Rev; 1999 Jun; 56(2):137-55. PubMed ID: 10373721 [TBL] [Abstract][Full Text] [Related]
13. Factors associated with psychotropic prescriptions, psychiatric hospitalization, and spending among Medicare beneficiaries under 65. Qian J; Wittayanukorn S; McGuffey G; Hansen R Disabil Health J; 2015 Jul; 8(3):424-33. PubMed ID: 25890881 [TBL] [Abstract][Full Text] [Related]
15. Association of chronic obstructive pulmonary disease maintenance medication adherence with all-cause hospitalization and spending in a Medicare population. Simoni-Wastila L; Wei YJ; Qian J; Zuckerman IH; Stuart B; Shaffer T; Dalal AA; Bryant-Comstock L Am J Geriatr Pharmacother; 2012 Jun; 10(3):201-10. PubMed ID: 22521808 [TBL] [Abstract][Full Text] [Related]
16. Spending on World Health Organization essential medicines in Medicare Part D, 2011-15: retrospective cost analysis. Li DG; Najafzadeh M; Kesselheim AS; Mostaghimi A BMJ; 2019 Jul; 366():l4257. PubMed ID: 31315833 [TBL] [Abstract][Full Text] [Related]
17. Evaluating the Effects of Pioneer Accountable Care Organizations on Medicare Part D Drug Spending and Utilization. Zhang Y; Caines KJ; Powers CA Med Care; 2017 May; 55(5):470-475. PubMed ID: 28060052 [TBL] [Abstract][Full Text] [Related]
18. Should healthy Medicare beneficiaries postpone enrollment in Medicare Part D? Atherly A; Dowd B Health Econ; 2009 Aug; 18(8):921-31. PubMed ID: 18972327 [TBL] [Abstract][Full Text] [Related]
19. Outpatient cancer drug costs: changes, drivers, and the future. Halbert RJ; Zaher C; Wade S; Malin J; Lawless GD; Dubois RW Cancer; 2002 Feb; 94(4):1142-50. PubMed ID: 11920485 [TBL] [Abstract][Full Text] [Related]
20. Use of and spending on supportive care medications among Medicare beneficiaries with cancer. Zuckerman IH; Davidoff AJ; Erten MZ; Stuart B; Shaffer T; Dougherty JS; Yong C Support Care Cancer; 2014 Aug; 22(8):2185-95. PubMed ID: 24659243 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]